Pulmonary arterial hypertension in children: A single center experience

Korean Circulation Journal

Volumn 38, Issue 12, 2008, Pages 644-650

  Kim, Hyung Woo ^a   Kim, Gi Beom ^a   Je, Hyun Gon ^a   Beak, Jae Suk ^a   Bae, Eun Jung ^a   Noh, Chung Il ^a   Choi, Jung Yeon ^a   Yun, Yong Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Child; Congenital; Epidemiology; Heart defects; Hypertension; Pulmonary

Indexed keywords

BOSENTAN; DIGOXIN; FUROSEMIDE; PROSTACYCLIN; SILDENAFIL; SPIRONOLACTONE;

AGE; ARTICLE; CHILD; CHILD DEATH; CHILD HEALTH CARE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; COUGHING; DEMOGRAPHY; DIASTOLE; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE SIZE; HEMODYNAMIC PARAMETERS; HUMAN; INFANT; KOREA; LIVER DYSFUNCTION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PEDIATRIC HOSPITAL; PROGNOSIS; PULMONARY HYPERTENSION; RASH; SEX DIFFERENCE; SURVIVAL RATE; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TRICUSPID VALVE REGURGITATION; UNIVERSITY HOSPITAL; WHEEZING;

EID: 58649106432     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2008.38.12.644     Document Type: Article

References (30)

1. Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003; 361: 1533-44.
2. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004; 351: 1655-65.
3. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl S): 5S-12S.
4. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107: 216-23.
5. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-36.
6. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-30.
7. Jung JW. Pulmonary arterial hypertension of congenital heart disease: from reversible pulmonary hypertension to Eisenmenger syndrome. Korean Circ J 2007; 37: 287-97.
8. Dalonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991; 115: 343-9.
9. Sandoval J, Bauerle O, Gomez A, et al. Primary pulmonary hypertension in children: clinical characterization and survival. J Am Coll Cardiol 1995; 25: 466-74.
10. Duffels MG, Engelfriet PM, Berger RM, et al. Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol 2007; 120: 198-204.
11. Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Eur Respir J 2003; 21: 155-76.
12. Rosenzweig EB, Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Pediatr Pulmonol 2004; 38: 2-22.
13. Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51: 1527-38.
14. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104: 2797-802.
15. Bossone E, Bodini BD, Mazza A, Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005; 127: 1836-43.
16. Rashid A, Ivy D. Pulmonary hypertension in children. Curr Paediatr 2006; 16: 237-47.
17. Thilenius OG, Nadas AS, Jockin H. Primary pulmonary vascular obstruction in children. Pediatrics 1965; 36: 75-87.
18. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336: 111-7.
19. Lee WD, Kim DS, Lee JH, et al. A clinical review of primary pulmonary hypertension. Korean Circ J 2003; 33: 507-12.
20. Suzuki K, Yamaki S, Mimori S, et al. Pulmonary vascular disease in Down's syndrome with complete atrioventricular septal defect. J Am Coll Cardiol 2000; 86: 434-7.
21. Lee WS, Kim KH, Jeong DH, et al. Clinical characteristics and prognostic factors of patients with severe pulmonary hypertension. Korean Circ J 2007; 37: 265-70.
22. Borgeson DD, Seward JB, Miller FA Jr, Oh JK, Tajik AJ. Frequency of Doppler measurable pulmonary artery pressures. J Am Soc Echocardiogr 1996; 9: 832-7.
23. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999; 99: 1197-208.
24. Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation 2005; 111: 3274-80.
25. Karatza AA, Bush A, Magee AG. Safety and efficacy of sildenafil therapy in children with pulmonary hypertension. Int J Cardiol 2005; 100: 267-73.
26. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
27. Barst RJ, Ivy D, Dingemanse J, et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 2003; 73: 372-82.
28. McMahon CJ, Penny DJ, Nelson DP, et al. Preterm infants with congenital heart disease and bronchopulmonary dysplasia: postoperative course and outcome after cardiac surgery. Pediatrics 2005; 116: 423-30.
29. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl S): 40S-7S.
30. Rubin LJ, Badesch DB. Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 2005; 143: 282-92.